ParaPRO has brought together experts in the field of head lice to provide guidance on technical and business issues. The group meets on a regular basis to review market research, receive updates on the regulatory and clinical trial process and provide input on proposed next steps.
|
• John Clark
|
UMass – Lice Genome |
|
• Judy Knight |
American Academy of Pediatrics |
|
• Annette Marette
|
Indiana State School Nurse Association |
|
• Charlene Morris
|
PA’s in Family Practice |
|
• Richard Pollack
|
Harvard School of Public Health |
It is anticipated that additional members will be added in the future as needs develop.
Ask your doctor if Natroba Topical Suspension is right for you or your child.
INDICATION
Natroba Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients four (4) years of age and older.
IMPORTANT SAFETY INFORMATION
Natroba Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic
exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants.
Most common adverse events were: application site redness (3%), redness and irritation of the eyes (2%) and application site irritation (1%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.